128 related articles for article (PubMed ID: 19285648)
1. Validation of serum biomarkers for detection of early-stage ovarian cancer.
Nosov V; Su F; Amneus M; Birrer M; Robins T; Kotlerman J; Reddy S; Farias-Eisner R
Am J Obstet Gynecol; 2009 Jun; 200(6):639.e1-5. PubMed ID: 19285648
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal evaluation of CA-125 velocity and prediction of ovarian cancer.
Xu JL; Commins J; Partridge E; Riley TL; Prorok PC; Johnson CC; Buys SS
Gynecol Oncol; 2012 Apr; 125(1):70-4. PubMed ID: 22198243
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a protein-based signature for the detection of ovarian cancer.
Kim K; Visintin I; Alvero AB; Mor G
Clin Lab Med; 2009 Mar; 29(1):47-55. PubMed ID: 19389550
[TBL] [Abstract][Full Text] [Related]
4. Estimating stage-specific sensitivity for cancer screening tests.
Pinsky P; Lange J; Etzioni R
J Med Screen; 2023 Jun; 30(2):69-73. PubMed ID: 36734139
[TBL] [Abstract][Full Text] [Related]
5. Monomeric myeloperoxidase is a specific biomarker for early-stage ovarian cancer.
Saed GM; Nawaz A; Alvero AA; Harper AK; Morris RT
Biomarkers; 2023 Dec; 28(7):663-671. PubMed ID: 37982229
[No Abstract] [Full Text] [Related]
6. Early Detection of Ovarian Cancer.
Sasamoto N; Elias KM
Cold Spring Harb Perspect Med; 2023 Nov; 13(11):. PubMed ID: 37604591
[TBL] [Abstract][Full Text] [Related]
7. Molecular Biomarkers for Early Detection and Prevention of Ovarian Cancer-A Gateway for Good Prognosis: A Narrative Review.
Yadav G; Vashisht M; Yadav V; Shyam R
Int J Prev Med; 2020; 11():135. PubMed ID: 33088463
[TBL] [Abstract][Full Text] [Related]
8. Short-term Endpoints for Cancer Screening Trials: Does Tumor Subtype Matter?
Owens L; Gogebakan KC; Menon U; Gulati R; Weiss NS; Etzioni R
Cancer Epidemiol Biomarkers Prev; 2023 Jun; 32(6):741-743. PubMed ID: 37259797
[TBL] [Abstract][Full Text] [Related]
9. Enigma of Ovarian Cancer - Early detection Challenges and Solutions!
Pradeep Y
J Midlife Health; 2024; 15(1):3-4. PubMed ID: 38764930
[No Abstract] [Full Text] [Related]
10. Sensitivity and Specificity of Selected Biomarkers and Their Combinations in the Diagnosis of Ovarian Cancer.
Englisz A; Smycz-Kubańska M; Mielczarek-Palacz A
Diagnostics (Basel); 2024 Apr; 14(9):. PubMed ID: 38732363
[TBL] [Abstract][Full Text] [Related]
11. Influence of serum transferrin concentration on diagnostic criteria for iron deficiency in chronic heart failure.
Graham FJ; Pellicori P; Masini G; Cuthbert JJ; Clark AL; Cleland JGF
ESC Heart Fail; 2023 Oct; 10(5):2826-2836. PubMed ID: 37400990
[TBL] [Abstract][Full Text] [Related]
12. Prediction of the treatment response in ovarian cancer: a ctDNA approach.
Sharbatoghli M; Vafaei S; Aboulkheyr Es H; Asadi-Lari M; Totonchi M; Madjd Z
J Ovarian Res; 2020 Oct; 13(1):124. PubMed ID: 33076944
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of proteins related to chemoresistance to paclitaxel and carboplatin in human SiHa cervical cancer cells via iTRAQ.
He Y; Han SB; Geng YN; Yang SL; Wu YM
J Gynecol Oncol; 2020 May; 31(3):e28. PubMed ID: 31912682
[TBL] [Abstract][Full Text] [Related]
14. Multi-biomarker panel signature as the key to diagnosis of ovarian cancer.
Muinao T; Deka Boruah HP; Pal M
Heliyon; 2019 Dec; 5(12):e02826. PubMed ID: 31867451
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic Biomarkers in the Management of Ovarian Cancer: Current Prospectives.
Singh A; Gupta S; Sachan M
Front Cell Dev Biol; 2019; 7():182. PubMed ID: 31608277
[TBL] [Abstract][Full Text] [Related]
16. Proteome profiling of low grade serous ovarian cancer.
Zadeh Fakhar HB; Zali H; Rezaie-Tavirani M; Darkhaneh RF; Babaabasi B
J Ovarian Res; 2019 Jul; 12(1):64. PubMed ID: 31315664
[TBL] [Abstract][Full Text] [Related]
17. Model-based analysis of treatment effects of paclitaxel microspheres in a microscopic peritoneal carcinomatosis model in mice.
Xie F; De Clercq K; Vervaet C; Van Bocxlaer J; Colin P; Vermeulen A
Pharm Res; 2019 Jun; 36(9):127. PubMed ID: 31236836
[TBL] [Abstract][Full Text] [Related]
18. Serum Biomarker Based Algorithms in Diagnosis of Ovarian Cancer: A Review.
Kumari S
Indian J Clin Biochem; 2018 Oct; 33(4):382-386. PubMed ID: 30319183
[TBL] [Abstract][Full Text] [Related]
19. Ovarian cancer screening-ultrasound; impact on ovarian cancer mortality.
Kamal R; Hamed S; Mansour S; Mounir Y; Abdel Sallam S
Br J Radiol; 2018 Oct; 91(1090):20170571. PubMed ID: 30102555
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
